SC 13G Filing

Company

Ernexa Therapeutics Inc.

Filed

August 5, 1999

Accession Number

0000932704-99-000015

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →